Clinical Trial Update: D2C7 for Adult Patients With Recurrent Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial update of D2C7 in adults with recurrent malignant glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Malignant Glioma

Drugs mentioned

• D2C7

Snippet

Sponsor: Darell Bigner | Conditions: Malignant Glioma, Brain Tumor, Recurrent | Phase 1 | Status: COMPLETED